A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension

Alcon Research408 enrolled

Overview

The purpose of this study is to evaluate the intraocular pressure(IOP)-lowering efficacy of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

408

Conditions

Glaucoma, Open-angle Ocular Hypertension

Interventions

Travoprost 0.004%/Timolol maleate 0.5% ophthalmic solutionDRUG

Investigational ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

Latanoprost 0.005%/Timolol 0.005% ophthalmic solutionDRUG

Commercially marketed ophthalmic solution intended for the treatment of open-angle glaucoma or ocular hypertension

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- As specified in protocol Exclusion Criteria: \- As specified in protocol

Locations (1)

European Facilitiies

Puurs, Belgium

Outcomes

Primary Outcomes

Mean Intraocular Pressure (IOP)

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.